Brunei News Gazette

Day: January 18, 2024

Fluence Named a Forbes 2024 Most Successful Mid-Cap Company

Ranked 37 of 100, Fluence is one of only a few cleantech companies named to the Forbes list ARLINGTON, Va., Jan. 18, 2024 (GLOBE NEWSWIRE) — Fluence Energy, Inc. (“Fluence”) (NASDAQ: FLNC), a leading global provider of energy storage products, services, and optimization software for renewables and storage, today announced that the company has been […]

The Sea Index and Yacht Club de Monaco’s leadership in eco-responsibility for yachts

The Sea Index and Yacht Club de Monaco’s leadership in eco-responsibility for yachts The Sea Index and Yacht Club de Monaco’s leadership in eco-responsibility for yachts MONACO, Jan. 18, 2024 (GLOBE NEWSWIRE) — A carbon footprint calculator for superyachts targeting the environmental objective to mitigate CO2 emissions in yachting. It is the Sea Index, a […]

Junshi Biosciences Announces JAMA Publication of Results from NEOTORCH, a Randomized Phase 3 Trial of Perioperative Toripalimab plus Chemotherapy for Patients with Resectable Non-Small Cell Lung Cancer

SHANGHAI, China, Jan. 17, 2024 (GLOBE NEWSWIRE) — Shanghai Junshi Biosciences Co., Ltd (“Junshi Biosciences,” HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced the publication of results from the prespecified interim analysis for event-free survival (EFS) in patients with stage III non-Small Cell […]

Nyxoah Announces 2024 Strategic Priorities

Nyxoah Announces 2024 Strategic Priorities Mont-Saint-Guibert, Belgium – January 17, 2024, 10:05pm CET / 4:05pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA), today announced, in anticipation of upcoming investor meetings, its strategic […]

FDA Issues Warning on Improper Use of Glutathione

MANILA: The Food and Drug Administration (FDA) has issued a cautionary statement regarding the use of glutathione, particularly emphasizing its approved application solely for Cisplatin chemotherapy treatment. FDA Attorney III Pamela Angeline Sevilla,…